# Sarepta Therapeutics, Inc.: Form 8-K, filed Sep 16, 2024

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2024-09-16
- Accepted by EDGAR: Sep 16, 2024, 08:51 ET
- Period: 2024-09-12
- Accession: 0000950170-24-106619
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/srpt-20240912.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/srpt-20240912.htm

Filed Sep 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-106619. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.